Омепразол Полфарма

Омепразол Полфарма is an intravenous proton pump inhibitor designed for acid-related gastrointestinal conditions. This EU-manufactured sodium salt formulation supports gastric health by reducing stomach acid production. Ideal for patients requiring injectable acid suppression therapy. Short-term use under medical supervision recommended.

Omeprazole Sodium is commonly used to manage conditions caused by excess stomach acid, such as peptic ulcers, erosive esophagitis, and gastroesophageal reflux disease (GERD). It may also be prescribed before surgery to reduce acid secretion or during critical care to prevent stress ulcers. Healthcare providers may use it when oral medication is not feasible, providing systemic acid control via injection.

When administered intravenously, Omeprazole Sodium begins to reduce gastric acid within the first hour, with peak effects typically observed within 2 to 6 hours. Patients often experience relief from symptoms such as heartburn and acid regurgitation. The medication works systemically to lower acid levels throughout the digestive tract.

This medication should only be handled and administered by trained healthcare professionals. It is not intended for self-use or unsupervised administration. Patients with known allergies to proton pump inhibitors or benzimidazoles should avoid this treatment. Always inform your healthcare provider about current medications and medical history before receiving intravenous therapy.

Omeprazole Sodium may interact with drugs metabolized by the liver, particularly those processed by the CYP2C19 enzyme system. Caution is advised when used alongside anticoagulants, antiplatelets, or medications that alter stomach pH. Alcohol and certain herbal supplements may also affect its efficacy. Always consult a healthcare professional before combining therapies.